1.
Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema
by Augustin, Matthias
Dermatology (Basel), 2015, Vol.231 (1), p.35-40
2.
Prevalence of Obesity in Patients with Psoriasis: Results of the National Study PsoHealth3
by Jacobi, Arnd
Dermatology (Basel), 2015, Vol.231 (3), p.231-238
3.
Loss of Interface Pressure in Various Compression Bandage Systems over Seven Days
by Protz, Kerstin
Dermatology (Basel), 2014, Vol.229 (4), p.343-352
4.
Evaluation of the Antipruritic Effects of Topical Pimecrolimus in Non-Atopic Prurigo Nodularis: Results of a Randomized, Hydrocortisone-Controlled, Double-Blind Phase II Trial
by Siepmann, Dorothee
Dermatology (Basel), 2014, Vol.227 (4), p.353-360
5.
Psychological Burden in Adult Neurofibromatosis Type 1 Patients: Impact of Disease Visibility on Body Image
by Granström, Sofia
Dermatology (Basel), 2012, Vol.224 (2), p.160-167
6.
Therapeutic Benefits in Atopic Dermatitis Care from the Patients' Perspective: Results of the German National Health Care Study ‘Atopic Health'
by Steinke, Sabine
Dermatology (Basel), 2014, Vol.228 (4), p.350-359
7.
Efficacy, Tolerability and Patient Benefit of Ultrasound-Assisted Wound Treatment versus Surgical Debridement: A Randomized Clinical Study
by Herberger, Katharina
Dermatology (Basel), 2011, Vol.222 (3), p.244-249
8.
Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study
by Radtke, Marc Alexander
Dermatology (Basel), 2016, Vol.232 (3), p.334-343
9.
Time Needed for Treatment Is the Major Predictor of Quality of Life in Psoriasis
by Blome, Christine
Dermatology (Basel), 2010, Vol.221 (2), p.154-159
10.
Characterization of Patient-Reported Outcomes in Moderate to Severe Psoriasis
by Krenzer, Stefanie
Dermatology (Basel), 2011, Vol.223 (1), p.80-86
11.
Plant-based ointments versus usual care in the management of chronic skin diseases: A comparative analysis on outcome and safety
by Jong, Miek C
Complementary therapies in medicine, 2013, Vol.21 (5), p.453-459
12.
Quality of Care in Chronic Leg Ulcer in the Community: Introduction of Quality Indicators and a Scoring System
by Augustin, Matthias
Dermatology (Basel), 2011, Vol.222 (4), p.321-329
13.
Double-Blind, Randomized, Intraindividual Comparison Study of the Efficacy of Prilocaine and Lidocaine in Tumescent Local Anesthesia
by Augustin, Matthias
Dermatology (Basel), 2010, Vol.221 (3), p.248-252
14.
Routine Skin Cancer Screening in Germany: Four Years of Experience from the Dermatologists' Perspective
by Kornek, Thomas
Dermatology (Basel), 2013, Vol.225 (4), p.289-293
15.
Making proper judgement when choosing a treatment for actinic keratosis
by Simon, Jan-Christoph
Expert review of dermatology, 2013, Vol.8 (6), p.595-603
16.
Clinical Features and Treatment Outcomes of Vitiligo from the Patients’ Perspective: Results of a National Survey in Germany
by Radtke, Marc A
Dermatology (Basel), 2010, Vol.220 (3), p.194-200
17.
Chronic venous leg ulcers: the future of cell-based therapies
by Augustin, Matthias
The Lancet (British edition), 2012, Vol.380 (9846), p.953-955
18.
German Adaptation of the Skindex-29 Questionnaire on Quality of Life in Dermatology: Validation and Clinical Results
by Augustin, Matthias
Dermatology (Basel), 2004, Vol.209 (1), p.14-20
19.
Chronic venous leg ulcers: the future of cell-based therapies
by Matthias Augustin
The Lancet (British edition), 2012, Vol.380 (9846), p.953
20.
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
by Bachelez, Hervé, Prof
The Lancet (British edition), 2015, Vol.386 (9993), p.552-561
